📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK. (2022)

First Author: Shields AM
Attributed to:  Gene Editing in X-Linked Agammaglobulinaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cei/uxac008

PubMed Identifier: 35641155

Publication URI: http://europepmc.org/abstract/MED/35641155

Type: Journal Article/Review

Volume: 209

Parent Publication: Clinical and experimental immunology

Issue: 3

ISSN: 0009-9104